Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
17.86
-0.43 (-2.32%)
At close: Jul 24, 2026, 4:00 PM EDT
17.75
-0.11 (-0.59%)
After-hours: Jul 24, 2026, 7:22 PM EDT
Quince Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Initiates $100 | Buy | Initiates | $100 | +460.07% | Jun 29, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $80 | Buy | Initiates | $80 | +348.05% | Jun 24, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $80 | Buy | Initiates | $80 | +348.05% | Jun 23, 2026 |
| Maxim Group | Maxim Group | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Feb 2, 2026 |
| Lucid Capital | Lucid Capital | Sell Downgrades n/a | Sell | Downgrades | n/a | n/a | Jan 30, 2026 |
| D. Boral Capital | D. Boral Capital | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jan 30, 2026 |
| Citizens JMP | Citizens JMP | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jan 30, 2026 |